Work

Safety and efficacy of casein kinase 1α and cyclin dependent kinase 7/9 inhibition in patients with relapsed or refractory AML: A first-in-human study of BTX-A51.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.7030

Authors: Brian Ball, Gautam Borthakur, Anthony Selwyn Stein, Kyle Chan, Dung Luong Thai, Eytan Stein

Institutions: City Of Hope National Medical Center, The University of Texas MD Anderson Cancer Center, Gilead Sciences (United States), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4286298165

Cites:

Cited by: 4

Related to: 10